Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents

Background and aim: Oral mesalazine and sulfasalazine (SASP) are key drugs for treating ulcerative colitis (UC). The efficacy of switching from one of the several mesalazine formulations to another is largely unknown. This study assessed the efficacy of switching among three types of mesalazine form...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasutomi, Eriko, Hiraoka, Sakiko, Yamamoto, Shumpei, Oka, Shohei, Hirai, Mami, Yamasaki, Yasushi, Inokuchi, Toshihiro, Kinugasa, Hideaki, Takahara, Masahiro, Harada, Keita, Kato, Jun, Okada, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970226/
https://www.ncbi.nlm.nih.gov/pubmed/31810227
http://dx.doi.org/10.3390/jcm8122109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970226/
https://www.ncbi.nlm.nih.gov/pubmed/31810227
http://dx.doi.org/10.3390/jcm8122109

Ejemplares similares